Founded in 1991, Vircell is a biotechnology company specialized in the development and production of ready-to-use reagents for the diagnosis of infectious disease in humans by different techniques – ranging from traditional cell culture to innovative developments in the field of molecular biology. Vircell supports diagnostic testing in over 90 countries across the five continents.

INDEPENDENT THIRD-PARTY MOLECULAR CONTROLS

Certify the efficiency, quality and reliability of your molecular infectious diseases testing

AMPLIRUN® Amplification Controls catalogue has over 145 products and has been developed to allow the amplification and testing of any region of the genome which is present in natural infections.

  • Purified nucleic acid, complete microbial genome. Any target can be amplified.
  • Valid for any molecular testing platform.
  • Precise concentration in copies/μl verified by Digital Droplet PCR (ddPCR).
  • Non-infectious material provided with inactivation certificate.
  • Lyophilized presentation ensures stability and reduces transport costs.

AMPLIRUN® TOTAL are full process controls designed to monitor the accuracy and precision of the complete analytical process: nucleic acid extraction, amplification and detection. 

  • Inactivated whole pathogen – Contains the entire genome and is compatible with any analysis.
  • Total control in a matrix that mimics a human specimen – For monitoring the entire process.
  • Quantified, low positive controls – Prepared to produce results at a significant clinical concentration.
  • Monodose format and lyophilized presentation – It guarantees stability and avoids handling and additional transport costs.
  • Non-infectious material with inactivation certificate.
  • Multiple platform compatibility.